Home  »  Trending   »  Ortho Clinical Diagnostics Holdings plc (OCDX) Jus...

Ortho Clinical Diagnostics Holdings plc (OCDX) Just Got Our Attention

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp

Ortho Clinical Diagnostics Holdings plc (NASDAQ:OCDX) went down by -1.70% from its latest closing price compared to the recent 1-year high of $22.99. The company’s stock price has collected 0.45% of gains in the last five trading sessions. Press Release reported 7 hours ago that Halper Sadeh LLP Investigates EPAY, VRS, HXOH, OCDX, ADTX; Shareholders are Encouraged to Contact the Firm

Is It Worth Investing in Ortho Clinical Diagnostics Holdings plc (NASDAQ :OCDX) Right Now?

Opinions of the stock are interesting as 1 analysts out of 5 who provided ratings for Ortho Clinical Diagnostics Holdings plc declared the stock was a “buy,” while 0 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


The average price from analysts is $24.27, which is $4.45 above the current price. OCDX currently public float of 118.15M and currently shorts hold a 1.77% ratio of that float. Today, the average trading volume of OCDX was 1.23M shares.

OCDX’s Market Performance

OCDX stocks went up by 0.45% for the week, with a monthly jump of 9.62% and a quarterly performance of 2.74%. The volatility ratio for the week stands at 3.41% while the volatility levels for the past 30 days are set at 3.73% for Ortho Clinical Diagnostics Holdings plc. The simple moving average for the period of the last 20 days is 1.46% for OCDX stocks with a simple moving average of 1.17% for the last 200 days.

Analysts’ Opinion of OCDX

Many brokerage firms have already submitted their reports for OCDX stocks, with Citigroup repeating the rating for OCDX by listing it as a “Buy.” The predicted price for OCDX in the upcoming period, according to Citigroup is $27 based on the research report published on October 04th of the previous year 2021.

Credit Suisse, on the other hand, stated in their research note that they expect to see OCDX reach a price target of $23. The rating they have provided for OCDX stocks is “Outperform” according to the report published on August 05th, 2021.

Barclays gave a rating of “Overweight” to OCDX, setting the target price at $24 in the report published on March 03rd of the previous year.

OCDX Trading at 2.29% from the 50-Day Moving Average

After a stumble in the market that brought OCDX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -11.79% of loss for the given period.

Volatility was left at 3.73%, however, over the last 30 days, the volatility rate increased by 3.41%, as shares surge +10.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.58% upper at present.

During the last 5 trading sessions, OCDX rose by +0.45%, which changed the moving average for the period of 200-days by +12.29% in comparison to the 20-day moving average, which settled at $20.08. In addition, Ortho Clinical Diagnostics Holdings plc saw -5.19% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at OCDX starting from Smith Christopher M, who sale 100,000 shares at the price of $21.10 back on Jan 03. After this action, Smith Christopher M now owns 367,360 shares of Ortho Clinical Diagnostics Holdings plc, valued at $2,109,800 using the latest closing price.

Schlesinger Michael A., the EVP, GC and Secretary of Ortho Clinical Diagnostics Holdings plc, sale 130,000 shares at $21.09 during a trade that took place back on Jan 03, which means that Schlesinger Michael A. is holding 87,637 shares at $2,741,622 based on the most recent closing price.

Stock Fundamentals for OCDX

Current profitability levels for the company are sitting at:

  • +6.10 for the present operating margin
  • +42.08 for the gross margin

The net margin for Ortho Clinical Diagnostics Holdings plc stands at -12.00. The total capital return value is set at 3.88, while invested capital returns managed to touch -8.13. Equity return is now at value -246.90, with -2.50 for asset returns.

>> 7 Top Picks for the Post-Pandemic Economy <<

The receivables turnover for the company is 4.78 and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.37.

Leave a Comment

Your email address will not be published. Required fields are marked *

Is Teradyne Inc. (TER) a Keeper?

Teradyne Inc. (NASDAQ:TER) went up by 3.99% from its latest closing price compared to the recent 1-year high of $168.91. The company’s stock price has




Download Free eBook For


100% free. stop anytime no spam